Trial Profile

Iontophoresis of Treprostinil to Enhance Wound Healing in Diabetic Foot Skin Ulcers

Status: Discontinued

Phase of Trial: Phase I/II

Latest Information Update: 15 Dec 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Treprostinil (Primary)
Indications Diabetic foot ulcer
Focus Proof of concept; Therapeutic Use
Acronyms InTREPiD

Most Recent Events

05 Dec 2023 Status changed from recruiting to discontinued.
05 Nov 2020 Planned primary completion date changed from 1 Jul 2020 to 1 Jul 2023.
16 Jan 2020 Planned End Date changed from 28 Feb 2022 to 1 Sep 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com